Sarpourian Fatemeh, Bahaadinbeigy Kambiz, Fatemi Aghda Seyed Ali, Fatehi Farhad, Ebrahimi Saeid, Fallahnezhad Meysam
Department of Health Information Management, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Digit Health. 2024 Nov 26;10:20552076241290957. doi: 10.1177/20552076241290957. eCollection 2024 Jan-Dec.
The rehabilitation process for cognitive disorders is long and complex, which can lead to reduced rehabilitation outcomes and reduced quality improvement. Thus, there is a need to use new methods to boost conventional rehabilitation (e.g., drug therapy, herbal therapy, paper, and pencil tasks). Innovations such as RehaCom can be helpful to remove the obstacles to treatment, but evidence for their effectiveness is limited.
To compare the effectiveness of RehaCom with other cognitive therapies (computer-based, non- computer) in patients with cognitive impairment (CI).
Eight bibliographic databases (PubMed, Cochran Library, Scopus, Science Direct, Web of Science, Embase, ProQuest, and google scholar) were used in this research. The initial search resulted in the extraction of 2466 articles; after the review of the title, abstract, and full text, 19 articles were selected. Quality assessment was performed using the CONSORT checklist. Then, data extraction was done using the form set by the researcher in Word 2016 software.
Overall, RehaCom achieved more positive clinical effects compared to other cognitive therapies (e.g., improvement in memory, attention, and motor function) on multiple sclerosis ( = 7), schizophrenia ( = 6), stroke ( = 3), Parkinson ( = 1), mild CI ( = 1), and acquired brain damage ( = 1). In six studies, a follow-up period of some weeks to 6 months has been used. Additionally, six studies used conventional therapy plus RehaCom for intervention. Except one study, all studies used RehaCom individual training.
This review provides evidence for the potential effectiveness of RehaCom for the improvement of clinical outcomes in patients with CI. However, more robust Randomised Controlled Trials (RCTs) are needed to confirm the observed positive effects.
认知障碍的康复过程漫长且复杂,这可能导致康复效果降低和质量提升受限。因此,需要采用新方法来增强传统康复手段(如药物治疗、草药治疗、纸笔任务)。诸如RehaCom之类的创新方法可能有助于消除治疗障碍,但其有效性的证据有限。
比较RehaCom与其他认知疗法(基于计算机的和非计算机的)对认知障碍(CI)患者的有效性。
本研究使用了八个文献数据库(PubMed、Cochrane图书馆、Scopus、科学Direct、科学网、Embase、ProQuest和谷歌学术)。初步检索共提取到2466篇文章;在对标题、摘要和全文进行审查后,筛选出19篇文章。使用CONSORT清单进行质量评估。然后,使用研究人员在Word 2016软件中设置的表格进行数据提取。
总体而言,与其他认知疗法相比,RehaCom在多发性硬化症(n = 7)、精神分裂症(n = 6)、中风(n = 3)、帕金森病(n = 1)、轻度CI(n = 1)和获得性脑损伤(n = 1)患者中取得了更积极的临床效果(如记忆力、注意力和运动功能的改善)。在六项研究中,随访期为几周至6个月。此外,六项研究使用传统疗法加RehaCom进行干预。除一项研究外,所有研究均采用RehaCom个体训练。
本综述为RehaCom改善CI患者临床结局的潜在有效性提供了证据。然而,需要更有力的随机对照试验(RCT)来证实观察到的积极效果。